Content related to Presentations Showcase Latest Pediatric GI Research

Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease characterized by accumulation of excess fat in the liver (hepatic steatosis) with associated inflammation (hepatitis). While there

Living donation and significantly lower wait times helped the program to perform 35 liver transplants in 2022.

Research at Children’s Hospital Los Angeles enables a novel compound to achieve a key designation from the Food and Drug Administration.

A clinical trial at Children’s Hospital Los Angeles is the first to study butyrate therapy in Hispanic children with ulcerative colitis.

The fellows will take part in five advanced pediatric gastroenterology and hepatology training programs at Children’s Hospital Los Angeles.

Children’s Hospital Los Angeles is one of the few pediatric medical centers in the nation to offer so many advanced training opportunities in gastroenterology.

A first-of-its-kind enhanced recovery after surgery protocol enables early extubation for pediatric liver transplant patients—including infants.

A new study at Children’s Hospital Los Angeles proposes the first evidence-based definition for the condition in neonates.